According to Beida Pharmaceutical's announcement, Kaiming Investment, the controlling shareholder of the company, added an additional pledge of 450,000 additional shares, accounting for 0.56% of its shares and 0.11% of the company's total share capital. The pledge was Zheshang Securities. The use of the pledge was supplementary pledge. The pledge period was October 23, 2026 to October 22, 2027. At the same time, Kaiming Investment processed a deferred repurchase of 2.75 million pledged shares, accounting for 3.43% of its shares and 0.65% of the company's total share capital. The expiration date after the extension was October 22, 2027, and the pledge was used for its own operation. This change does not involve additional financing. As of the disclosure date of the announcement, Kaiming Investment and its co-actors have pledged a total of 484.28,500 shares, accounting for 53.21% of its shares and 11.44% of the company's total share capital. There is no risk of liquidation of the pledged shares, and it will not lead to a change in the actual control of the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.